News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Feds Seeking $1B From Johnson & Johnson (JNJ) Over Risperdal Marketing



5/13/2011 6:22:07 AM

Federal prosecutors are seeking roughly $1 billion to resolve a long-running probe into Johnson & Johnson's marketing of the antipsychotic drug Risperdal, according to people familiar with the matter. A settlement of around $1 billion would be among the largest in a string of settlements related to off-label marketing of drugs in recent years, and would likely have a material impact on J&J's quarterly financial results.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES